Wedbush Maintains Outperform on Trulieve Cannabis, Lowers Price Target to $6
Portfolio Pulse from richadhand@benzinga.com
Wedbush analyst Gerald Pascarelli has maintained an Outperform rating on Trulieve Cannabis (OTC:TCNNF) but lowered the price target from $8 to $6.

August 11, 2023 | 2:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Trulieve Cannabis's price target has been lowered from $8 to $6 by Wedbush, though the Outperform rating is maintained.
The lowering of the price target by a respected analyst could lead to a negative sentiment among investors, potentially causing a short-term decrease in the stock price. However, the maintained Outperform rating indicates that the analyst still sees potential in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100